Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.07.001 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Shinya Goto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan. Electronic address: shinichi@is.icc.u-tokai.ac.jp. Hauptthemen laut MEDLINE: Carboxypeptidase B2, Pulmonary Embolism, Thrombosis. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan. Electronic address: shinichi@is.icc.u-tokai.ac.jp.
- Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.
Zitieren
APA
Goto, S., & Goto, S. (2023). Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.07.001
Vancouver
Goto S, Goto S. Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.07.001
BibTeX
@article{Goto2023,
author = {Goto, Shinya and Goto, Shinichi},
title = {Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.07.001}
}
EUVIMED